A 12% surge in RoboStrategy shares on Monday followed the robotics firm’s announcement that it successfully raised $33.9 million in private placements. The move marks a continuation of the company's aggressive growth trajectory, with the stock price climbing over 50% throughout the last month of trading.
A 12% jump in morning trading pushed Satellos Bioscience shares to C$11.39 on Monday, as the company’s Duchenne muscular dystrophy treatment received fast track designation from the U.S. Food and Drug Administration. This regulatory milestone extends the biotech firm’s year-to-date gains to 44% on the Toronto market.
Shares of PetMed Express surged 22% to $2.15 on Monday following a revised buyout offer from SilverCape Investments. The firm, which already holds a 12% stake in the online pet pharmacy, proposed a cash acquisition price of $3 per share, citing a need to address the company’s ongoing financial decline.
With regulatory clearance in hand, Palisade Bio is moving its lead candidate into human testing. The company announced Monday that the FDA approved its investigational new drug application for PALI-2108, triggering a 12% surge in share price as investors cheered the path toward treating moderate to severe ulcerative colitis.
After months of executive volatility and investor pressure, Fortune Brands Innovations has appointed Jesse Singh as its new chief executive officer. The veteran industrial leader, formerly at the helm of The Azek Company, joins the board effective Monday to stabilize a company that recently abandoned a previous succession plan.
Shares of 4D Molecular Therapeutics climbed 7% to $12.40 Monday following the company’s announcement of a $200 million credit facility with Hercules Capital. The infusion of capital strengthens a balance sheet already bolstered by $458 million in cash and marketable securities reported at the end of the first quarter.
BioCryst is shuttering its internal discovery operations in Birmingham, Alabama, as the biotechnology firm pivots toward an external-innovation model. By abandoning its Discovery Center of Excellence, the company aims to streamline its rare-disease development pipeline and improve capital efficiency under the direction of Chief Executive Charlie Gayer.
Investors pushed NN shares up 49% to $4.11 in Monday’s premarket trading after the company announced a surge in immediate-supply awards for liquid cooling components. These new contracts bolster the firm’s role in Nvidia’s artificial intelligence data center ecosystem, building on a year that has already seen the stock price double.
A 1.7 billion euro valuation sits at the heart of Digi Communications' move to list its Spanish subsidiary on local stock exchanges. By offering newly issued shares alongside existing stock, the Romanian telecommunications operator aims to accelerate growth in a market where it currently serves as the fourth-largest mobile provider.
Steven Pelton is stepping down as president and chief executive of Aegis Brands, vacating his role before a replacement is named. The owner of the St. Louis Bar & Grill and Sweet Jesus franchises confirmed the departure, noting that Pelton is leaving to pursue an unspecified professional opportunity elsewhere.
Verizon Communications is bracing for a significant financial hit this quarter, projecting charges of up to $1.55 billion. The bulk of the expense stems from a major restructuring of its international operations and ongoing efforts to trim its workforce through a series of sweeping severance packages and asset rationalization.
With shares climbing 11% to $26.65 in premarket trading, FuelCell Energy confirmed a $49 million financing package from the Export-Import Bank of the United States. The capital injection arrives as the company pushes to expand its clean-energy footprint across international markets, following a year where its stock value tripled.
Investors will soon have access to cash-settled futures contracts tied to central bank policy decisions and U.S. natural gas storage reports. Intercontinental Exchange announced the new suite of products, designed to provide a regulated, centrally-cleared environment for betting on macroeconomic shifts and energy inventory fluctuations starting August 10.
After two decades navigating the complexities of biotechnology finance, Eric Hyllengren is stepping into the role of chief financial officer at Tenaya Therapeutics. Starting July 13, he will take charge of the company’s capital allocation and corporate strategy as it pushes its cardiovascular research toward clinical milestones.
Shares of Evommune plummeted 29% in premarket trading Monday after the biotechnology firm reported that its experimental drug, EVO756, failed to meet primary efficacy goals in a Phase 2b study targeting chronic spontaneous urticaria, a condition characterized by persistent, debilitating hives that resist standard antihistamine treatments.
Shares of drone-autonomy software firm Swarmer surged 7.2% to $43.95 in Monday’s premarket trading, following a disclosure that an existing contract will generate an additional $1.02 million in revenue. The company, which debuted on the public market at $5 per share in March, continues to see rapid valuation growth.
After holding the top spot for just over a year, Copart CEO Jeff Liaw will vacate his position at the end of July. The Dallas-based online vehicle auction firm announced Monday that Executive Chairman Jay Adair is returning to the chief executive role, effectively reversing the leadership structure established in 2022.
One share of the newly independent Honeywell Aerospace for every two shares of the former parent company: that is the math behind the industrial giant’s final structural pivot. The move formally concludes a multiyear effort to unwind Honeywell’s sprawling conglomerate model into a leaner, specialized operation.
A key European regulatory committee has recommended expanding the approval of AbbVie’s blockbuster drug Rinvoq to treat severe alopecia areata and non-segmental vitiligo. If the European Commission follows this advice, the medication would become the first systemic treatment option available across Europe for patients battling the most common form of vitiligo.
Vancouver-based Zymeworks has reached an agreement to acquire Theravance Biopharma for approximately $929 million, a move centered on the acquisition of the chronic obstructive pulmonary disease treatment Yupelri. The all-cash offer arrives just months after a failed clinical trial forced Theravance to overhaul its business strategy.
A $752 million acquisition of Cardinal Midstream Partners’ operating subsidiaries will bolster San Mateo Midstream’s footprint across the Delaware Basin. The deal, announced Monday, integrates a cryogenic processing plant and 145 miles of pipeline into the joint venture’s existing infrastructure, signaling a significant expansion of its gathering and processing capabilities.
A 12% jump in share price propelled Bridgepoint Group to the top of the Stoxx 600 index on Tuesday after the firm announced its acquisition of Kayne Anderson Real Estate. The $1.39 billion deal marks a significant expansion for the London-listed investment company, pushing its total assets under management to $117 billion.
Private equity giant CVC Capital Partners is moving to acquire Italian ingredients manufacturer Irca from Advent, marking another significant expansion in the food production sector. The deal follows a period of rapid scaling for the business, which has seen its annual revenue quadruple under its previous ownership to 1.5 billion euros.
A lightning-sparked wildfire burning near the Larocque East uranium project in northern Saskatchewan has forced IsoEnergy to pull its field crews from the site. While the blaze does not currently threaten the infrastructure directly, the company deemed the surrounding conditions too hazardous to continue active exploration work.
With shares surging 23% in premarket trading, Comcast revealed plans to carve its massive empire into two distinct entities. The move effectively separates the company’s struggling legacy broadband and cable operations from its high-growth media portfolio, marking a definitive pivot for the entertainment titan.
With an $8 billion price tag, Rocket Lab is moving to absorb satellite operator Iridium Communications, a deal that fuses launch capabilities with a global orbital network. The acquisition represents a major consolidation in the American space sector, aiming to integrate spacecraft manufacturing with established on-orbit communications infrastructure.
A sharp rotation in Chinese equity markets saw investors abandon overstretched artificial intelligence stocks on Monday, pouring capital into the healthcare sector instead. The shift triggered one of the most significant single-day rallies for biotech indices in two years, leaving tech-heavy benchmarks trailing behind.
A 0.6% climb in S&P 500 futures sets a positive tone for Wall Street, contrasting with a fragmented session across European exchanges. While investors navigate shifting bond yields, Brent crude prices pushed toward $73 a barrel, reflecting a broader appetite for risk in early trading across Asian and American markets.
Diamond Electric Holdings Co. Ltd. reported a significant contraction in net profit for the fiscal year ending March 31, 2026, as the company’s bottom line fell to 217 million yen from 411 million yen in the previous year, despite a moderate rise in overall top-line revenue.
A 0.9 percent dip in net profit to 2.05 billion yen marks a challenging nine-month period for Nagaileben Co. Ltd. through May 31. While the Tokyo-listed medical apparel manufacturer faced broader revenue contraction, the company managed to boost its per-share earnings to 67.86 yen, up from 66.53 yen in the previous year.
